East Asia Pharma (SHG: 605177)

East Asia Pharma is a corporation based in Taizhou City, China. Established in 1998, the firm mainly engaged in the bulk pharmaceutical chemicals and intermediates in the fields, such as cardiovascular, anti-aging dementia, digestive system, diabetic neuropathy, anti-pathogenic microorganisms (including β-lactam antibiotics, carbapenems semi-synthetic antibiotics, and synthetic antibacterial, antifungal, antiviral) infection and central nervous system. The assets of the firm are managed by its executive team.